Berberine as a Potential Multi-Target Agent for Metabolic Diseases: A Review of Investigations for Berberine
2
Endocrinology Department, Jiaxing Hospital of Traditional Chinese Medicine, Jiaxing 314001,China
|
Publication type: Journal Article
Publication date: 2020-09-11
scimago Q3
wos Q3
SJR: 0.535
CiteScore: 4.4
Impact factor: 2.0
ISSN: 18715303, 22123873
PubMed ID:
32914727
Immunology and Allergy
Endocrinology, Diabetes and Metabolism
Abstract
Berberine (BBR) is a botanic alkaloid extracted from Coptis chinensis (Huanglian), which has various properties, compassing anti-hyperglycemia, anti-obesity, anti-inflammation, and improves insulin resistance, etc. Several researches have confirmed that BBR has effective actions in treating glycolipid metabolic abnormalities. BBR is also beneficial in regulating intestinal flora. Metabolic diseases are strongly associated with metabolic disorders, which are growing in the population and dramatically impacting human health, which also have been considered as a leading cause of diseases and death globally. This review is to evaluate the metabolic properties of BBR, and its potential application to the treatment of metabolic diseases by its effective actions on metabolic disorders.
Found
Nothing found, try to update filter.
Found
Nothing found, try to update filter.
Top-30
Journals
|
1
2
|
|
|
Journal of Ethnopharmacology
2 publications, 8.7%
|
|
|
Evidence-based Complementary and Alternative Medicine
2 publications, 8.7%
|
|
|
Journal of Diabetes Research
2 publications, 8.7%
|
|
|
Endocrine, Metabolic and Immune Disorders - Drug Targets
1 publication, 4.35%
|
|
|
Molecules
1 publication, 4.35%
|
|
|
Pharmaceutics
1 publication, 4.35%
|
|
|
Frontiers in Medicine
1 publication, 4.35%
|
|
|
Frontiers in Cellular and Infection Microbiology
1 publication, 4.35%
|
|
|
Frontiers in Endocrinology
1 publication, 4.35%
|
|
|
Phytotherapy Research
1 publication, 4.35%
|
|
|
BioMed Research International
1 publication, 4.35%
|
|
|
Journal of Gastrointestinal Oncology
1 publication, 4.35%
|
|
|
Crystal Research and Technology
1 publication, 4.35%
|
|
|
Journal of Advanced Research
1 publication, 4.35%
|
|
|
Heliyon
1 publication, 4.35%
|
|
|
Russian Chemical Reviews
1 publication, 4.35%
|
|
|
Phytomedicine
1 publication, 4.35%
|
|
|
Chemical Engineering Journal
1 publication, 4.35%
|
|
|
European Journal of Medicinal Chemistry
1 publication, 4.35%
|
|
|
Biointerphases
1 publication, 4.35%
|
|
|
1
2
|
Publishers
|
1
2
3
4
5
6
7
|
|
|
Elsevier
7 publications, 30.43%
|
|
|
Hindawi Limited
4 publications, 17.39%
|
|
|
Frontiers Media S.A.
3 publications, 13.04%
|
|
|
Wiley
3 publications, 13.04%
|
|
|
MDPI
2 publications, 8.7%
|
|
|
Bentham Science Publishers Ltd.
1 publication, 4.35%
|
|
|
AME Publishing Company
1 publication, 4.35%
|
|
|
Autonomous Non-profit Organization Editorial Board of the journal Uspekhi Khimii
1 publication, 4.35%
|
|
|
American Vacuum Society
1 publication, 4.35%
|
|
|
1
2
3
4
5
6
7
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.
Are you a researcher?
Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
23
Total citations:
23
Citations from 2024:
10
(43.48%)
Cite this
GOST |
RIS |
BibTex |
MLA
Cite this
GOST
Copy
Wang S. et al. Berberine as a Potential Multi-Target Agent for Metabolic Diseases: A Review of Investigations for Berberine // Endocrine, Metabolic and Immune Disorders - Drug Targets. 2020. Vol. 21. No. 6. pp. 971-979.
GOST all authors (up to 50)
Copy
Wang S., ZHANG X., Cai B., Qiu C. Berberine as a Potential Multi-Target Agent for Metabolic Diseases: A Review of Investigations for Berberine // Endocrine, Metabolic and Immune Disorders - Drug Targets. 2020. Vol. 21. No. 6. pp. 971-979.
Cite this
RIS
Copy
TY - JOUR
DO - 10.2174/1871530320666200910105612
UR - https://doi.org/10.2174/1871530320666200910105612
TI - Berberine as a Potential Multi-Target Agent for Metabolic Diseases: A Review of Investigations for Berberine
T2 - Endocrine, Metabolic and Immune Disorders - Drug Targets
AU - Wang, Sheng-Ju
AU - ZHANG, Xu
AU - Cai, Baochao
AU - Qiu, Chen
PY - 2020
DA - 2020/09/11
PB - Bentham Science Publishers Ltd.
SP - 971-979
IS - 6
VL - 21
PMID - 32914727
SN - 1871-5303
SN - 2212-3873
ER -
Cite this
BibTex (up to 50 authors)
Copy
@article{2020_Wang,
author = {Sheng-Ju Wang and Xu ZHANG and Baochao Cai and Chen Qiu},
title = {Berberine as a Potential Multi-Target Agent for Metabolic Diseases: A Review of Investigations for Berberine},
journal = {Endocrine, Metabolic and Immune Disorders - Drug Targets},
year = {2020},
volume = {21},
publisher = {Bentham Science Publishers Ltd.},
month = {sep},
url = {https://doi.org/10.2174/1871530320666200910105612},
number = {6},
pages = {971--979},
doi = {10.2174/1871530320666200910105612}
}
Cite this
MLA
Copy
Wang, Sheng-Ju, et al. “Berberine as a Potential Multi-Target Agent for Metabolic Diseases: A Review of Investigations for Berberine.” Endocrine, Metabolic and Immune Disorders - Drug Targets, vol. 21, no. 6, Sep. 2020, pp. 971-979. https://doi.org/10.2174/1871530320666200910105612.